Health Sciences Acquisitions Corp. 2 (HSAQ)
Stock Price:
$11.10 USD
0.00 (0.00%)
Updated Sep 18, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
221.20M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
n/a |
| Shares Out |
19.93M |
| EPS (ttm) |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Sep 18, 2020 |
| Last Price |
$11.10 |
| Previous Close |
$11.10 |
| Change ($) |
0.00 |
| Change (%) |
0.00% |
| Day's Open |
11.11 |
| Day's Range |
11.00 - 11.22 |
| Day's Volume |
10,250 |
| 52-Week Range |
10.83 - 12.50 |
More Stats
| Market Cap |
221.20M |
| Enterprise Value |
n/a |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
19.93M |
| Float |
n/a |
| EPS (basic) |
n/a |
| EPS (diluted) |
n/a |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
1,777 |
| Short Ratio |
0.01 |
| Short % of Float |
0.01% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
n/a |
| Revenue |
n/a |
| Operating Income |
n/a |
| Net Income |
n/a |
| Free Cash Flow |
n/a |
| Net Cash |
n/a |
| Net Cash / Share |
0.00 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Overview
No financial data available for this stock yet.
Company Details
| Full Name |
Health Sciences Acquisitions Corp. 2 |
| Country |
United States |
| CEO |
Roderick T. Wong |
Stock Information
| Ticker Symbol |
HSAQ |
| Stock Exchange |
NASDAQ |
| Sector |
Financial Services |
| Industry |
Shell Companies |
| Unique Identifier |
NASDAQ: HSAQ |
| IPO Date |
August 4, 2020 |
Description
Health Sciences Acquisitions Corporation 2 intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. Address: 40,10th Avenue, New York, NY, United States, 10014